Fatty acids, triglycerides and syndromes of insulin resistance

Prostaglandins Leukotrienes and Essential Fatty Acids

Volumn 57, Issue 4-5, 1997, Pages 379-385

  Storlien, L H ^a   Kriketos, A D ^a   Calvert, G D ^a   Baur, L A ^b   Jenkins, A B ^a  

^a UNIVERSITY OF WOLLONGONG   (Australia)

^b UNIVERSITY OF SYDNEY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

FATTY ACID; MEMBRANE LIPID; PLASMINOGEN ACTIVATOR INHIBITOR; TRIACYLGLYCEROL;

AORTA; CONFERENCE PAPER; HUMAN; INSULIN RESISTANCE; LIPID ANALYSIS; LIPID COMPOSITION; MUSCLE FIBER MEMBRANE; NONHUMAN; PRIORITY JOURNAL; THROMBOSIS;

ANIMALIA;

EID: 0030867111     PISSN: 09523278     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0952-3278(97)90414-2     Document Type: Conference Paper

References (44)

1. Reaven G. M. Role of insulin resistance in human disease (Syndrome X): an expanded definition. Ann Rev Med 1993; 44: 121-131.
2. Björntorp P. Visceral fat accumulation: the missing link between psychosocial factors and cardiovascular disease? J Int Med 1991; 230: 195-201.
3. Katz A., Nyomba B. L., Bogardus C. No accumulation of glucose in human skeletal muscle during euglycemic hyperinsulinemia. Am J Physiol 1988; 255: E942-E945.
4. Ziel F. H., Venkatesan N., Davidson M. B. Glucose transport is rate limiting for skeletal muscle glucose metabolism in normal and STZ-induced diabetic rats. Diabetes 1988; 37: 885-890.
5. Storlien L. H., Kraegen E. W., Chisholm D. J., Ford G. L., Bruce D. G., Pascoe W. S. Fish oil prevents insulin resistance induced by high-fat feeding in rats. Science 1987; 237: 885-888.
6. Borkman M., Storlien L. H., Pan D. A., Jenkins A. B., Chisholm D.J., Campbell L. V. The relationship between insulin sensitivity and the fatty acid composition of phospholipids of skeletal muscle. N Engl J Med 1993; 328: 238-244.
7. Pan D. A., Lillioja S., Milner M. R., et al. Skeletal muscle membrane lipid composition is related to adiposity and insulin action. J Clin Invest 1995; 96: 2802-2808.
8. Storlien L. H., Jenkins A. B., Chisholm D. J., Pascoe W. S., Khouri S., Kraegen E. W. Influence of dietary fat composition on development of insulin resistance in rats. Relationship to muscle triglyceride and w-3 fatty acids in muscle phospholipids. Diabetes 1991; 40: 280-289.
9. Vessby B. S., Tengblad S., Lithell H. Insulin sensitivity is related to the fatty acid composition of serum lipids and skeletal muscle phospholipids in 70-year-old men. Diabetologia 1994; 37: 1044-1050.
10. Lavau M., Susini C. [U-14C]glucose metabolism in vivo in rats rendered obese by a high fat diet. J Lipid Res 1975; 16: 134-142.
11. Susini C., Lavau M. In-vitro and in-vivo responsiveness of muscle and adipose tissue to insulin in rats rendered obese by a high-fat diet. Diabetes 1978; 27: 114-120.
12. Kraegen E. W., James D. E., Jenkins A. B., Chisholm D. J. Dose-response curves for in vivo insulin sensitivity in individual tissues in rats. Am J Physiol 1985; 248: E353-E362.
13. Jenkins A. B., Furler S. M., Kraegen E. W. 2-deoxy-glucose metabolism in individual tissues of the rat in vivo. Int J Biochem 1986; 18: 311-318.
14. Wong S. H., Nestel P. J., Trimble R. P., Storer G. B., Illman R. J., Topping D. L. The adaptive effects of dietary fish and safflower oil on lipid and lipoprotein metabolism in perfused rat liver. Biochim Biophys Acta 1984; 792: 103-109.
15. Bringolf M., Zaragoza N., Rivier D., Felber J-P. Studies on the metabolic effects induced in the rat by a high-fat diet. Inhibition of pyruvate metabolism in diaphragm in vitro and its relation to the oxidation of fatty acids. Eur J Biochem 1972; 26: 360-367.
16. Randle P. J., Garland P. B., Hales C. N., Newsholme E. A. The glucose fatty-acid cycle, its role in insulin sensitivity and the metabolic disturbances of diabetes mellitus. Lancet 1963; 1: 785-789.
17. Randle P. J., Kerbey A. L., Espinal J. Mechanisms decreasing glucose oxidation in diabetes and starvation: role of lipid fuels and hormones. Diab Metab Rev 1988; 4: 623-638.
18. Field C. J., Ryan E. A., Thomson A. R., Clandinin M. T. Dietary fat and the diabetic state alter insulin binding and the fatty acyl composition of the adipocyte plasma membrane. Biochem J 1988; 253: 417-424.
19. Grunfeld C., Baird K., Kahn C. R. Maintenance of 3T3-L1 cells in culture media containing saturated fatty acids decreases insulin binding and insulin action. Biochem Biophys Res Commun 1981; 103: 219-226.
20. Sohal P. S., Baracos V. E., Clandinin M. T. Dietary w3 fatty acid alters prostaglandin synthesis, glucose transport and protein turnover in skeletal muscle of healthy and diabetic rats. Biochem J 1992; 286: 405-411.
21. Clandinin M. T., Cheema S., Field C. J., Baracos V. E. Dietary lipids influence insulin action. Klimes I., Howard B. V., Storlien L. H., Sebokova E., eds. Dietary lipids and insulin action. New York: New York Acad Sci, 1993: 151-163.
22. Thorburn A. W., Storlien L. H., Jenkins A. B., Khouri S., Kraegen E. W. Fructose-induced in vivo insulin resistance and elevated plasma triglyceride levels in rats. Am J Clin Nutr 1989; 49: 1155-1163.
23. Reaven G. M. Insulin resistance, hyperinsulinemia, hypertriglyceridemia and hypertension: parallels between human disease and rodent models. Diabetes Care 1991; 14: 195-202.
24. Pan D. A., Storlien L. H. Dietary lipid profile is a determinant of tissue phospholipid fatty acid composition and rate of weight gain in rats. J Nutr 1993; 123: 512-519.
25. Baur L. A., O'Connor J., Pan D. A., Kriketos A. D., Storlien L. H. Interrelationships between type of feeding, skeletal muscle lipid profile and glucoregulation in infants. Metabolism, in press.
26. Prochazka M., Lillioja S., Tait J. F., et al. Linkage of chromosomal markers on 4q with a putative gene determining maximal insulin action in Pima Indians. Diabetes 1993; 42: 514-519.
27. Reaven P. D., Grasse B. J., Tribble D. L. Effects of linoleateenriched and oleate-enriched diets in combination with a-tocopherol on the susceptibility of LDL and LDL subfractions to oxidative modification in humans. Arterioscler Thromb 1994; 14: 557-566.
28. Collier A., Wilson R., Bradley H., Thomson J. A., Small M. Free radical activity in type II diabetes. Diabetic Med 1990; 7: 27-30.
29. Yue D. K., McLennan S., Fisher E., et al. Ascorbic acid metabolism and polyol pathway in diabetes. Diabetes 1988; 38: 257-261.
30. Paolisso G., D'Amore A., Guigliano D., Ceriello A., Varricchio M, D'Onofrio F. Pharmacologic doses of vitamin E improve insulin action in healthy subjects and non-insulin-dependent diabetic patients. Am J Clin Nutr 1993; 57: 650-656.
31. Paolisso G., D'Amore A., Balbi V., et al. Plasma vitamin C affects glucose homeostasis in healthy subjects and in non-insulin-dependent diabetics. Am J Physiol 1994; 266: E261-E268.
32. Auwerx J., Bouillon R., Collen D., Geboers J. Tissue-type plasminogen activator antigen and plasminogen activator inhibitor in diabetes mellitus. Arteriosclerosis 1988; 8: 68-72.
33. Juhan-Vague I., Roul C., Alessi M. C., Ardisonne J. P., Heim M., Vague J. Increased plasminogen activator inhibitor activity in non-insulin dependent diabetic patients. Relationship with plasma insulin. Thromb Haemostas 1993; 61: 370-373.
34. Bahru Y., Kesteven P., Alberti K. G. M. M., Walker M. Decreased plasminogen activator inhibitor-1 activity in newly diagnosed Type 2 diabetic patients following dietary modification. Diabetic Med 1993; 10: 802-806.
35. Kooistra T., Bosma P. J., Tons H. A. M., van den Berg A. P., Meyer P., Princen H. M. G. Plasminogen activator inhibitor 1: biosynthesis and mRNA level are increased by insulin in cultured human hepatocytes. Thromb Haemost 1989; 62: 723-728.
36. Sundell I. B., Dahlen G. H., Ranby M. Diet-induced changes in glucose and triglycerides are associated with changes in plasminogen activator inhibitor levels. Haemostasis 1991; 21: 175-190.
37. Skartlien A. H., Beckmann S. L., Holme I., Hjermann I., Prydz H. Effect of alteration in triglyceride levels on Factor VII phospholipid complexes in plasma. Arterioscler Thromb 1989; 9: 798-801.
38. Hoffman C. J., Miller R. H., Hultin M. B . Correlation of factor VII activity and antigen with cholesterol and triglycerides in healthy young adults. Arterioscler Thromb 1992; 12: 267-270.
39. Olivieri O., Negri M., De Gironcoli M., et al. Effects of dietary fish oil on malondialdehyde production and glutathione peroxidase activity in hyperlipidaemic patients. Scand J Clin Lab Invest 1988; 48: 659-665.
40. Storlien L. H., Pan D. A., Kriketos D. A., et al. Skeletal muscle membrane lipids and insulin resistance. Lipids 1996, 31: S261-S265.
41. Witztum J. L., Steinberg D. Role of oxidized low density lipoprotein in atherogenesis. J Clin Invest 1991; 88: 1785-1792.
42. Berliner J. A., Navab M., Fogelman A. M., et al. Atherosclerosis: Basic mechanisms. Oxidation, inflammation, and genetics. Circulation 1995; 91: 2488-2496.
43. Navarro M. D., Hortelano P., Periago J. L., Pita M. L. Effect of dietary olive oil and sunflower oils on the lipid composition of the aorta and platelets and on blood eicosanoids in rats. Arterioscler Thromb 1992; 12: 830-835.
44. Storlien L. H, Baur L. A., Kriketos A. D., et al. Dietary fats and insulin action. Diabetologia 1996; 39: 621-631.